These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9690546

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 4. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K, Toki T, Shimizu M, Shiozawa T, Fujii S, Nikaido T, Konishi I.
    Int J Gynecol Pathol; 2003 Oct 17; 22(4):334-40. PubMed ID: 14501812
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Oct 17; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 6. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N, Mylonas I, Jeschke U, Thaqi A, Kuhn C, Puchner T, Friese K.
    Anticancer Res; 2007 Oct 17; 27(4A):2027-33. PubMed ID: 17649817
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.
    Villena-Heinsen C, Meyberg R, Axt-Fliedner R, Reitnauer K, Reichrath J, Friedrich M.
    Anticancer Res; 2002 Oct 17; 22(4):2261-7. PubMed ID: 12174912
    [Abstract] [Full Text] [Related]

  • 8. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
    Giuffrè G, Arena F, Scarfì R, Simone A, Todaro P, Tuccari G.
    Oncol Rep; 2006 Aug 17; 16(2):257-63. PubMed ID: 16820900
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y, Dang Q.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul 17; 32(7):418-21. PubMed ID: 9639729
    [Abstract] [Full Text] [Related]

  • 11. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
    Uchikawa J, Shiozawa T, Shih HC, Miyamoto T, Feng YZ, Kashima H, Oka K, Konishi I.
    Cancer; 2003 Nov 15; 98(10):2207-13. PubMed ID: 14601091
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology].
    Amălinei C, Căruntu ID, Balan R, Cianga C, Cianga P.
    Rev Med Chir Soc Med Nat Iasi; 2008 Dec 15; 112(2):437-48. PubMed ID: 19295017
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas.
    Saegusa M, Okayasu I.
    J Pathol; 1997 Aug 15; 182(4):429-36. PubMed ID: 9306964
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma.
    Gehrig PA, Van Le L, Olatidoye B, Geradts J.
    Cancer; 1999 Nov 15; 86(10):2083-9. PubMed ID: 10570435
    [Abstract] [Full Text] [Related]

  • 17. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL, Shajahan S, Khattar NH, Wilder DM, Yin J, Rushing RS, Beaven R, Kaetzel C, Ueland FR, van Nagell JR, Kryscio RJ, Lele SM.
    Gynecol Oncol; 2004 Feb 15; 92(2):553-8. PubMed ID: 14766247
    [Abstract] [Full Text] [Related]

  • 18. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX, Zhang SL, Gao S, Lu JM, Dong F.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun 15; 41(6):395-8. PubMed ID: 16831363
    [Abstract] [Full Text] [Related]

  • 19. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
    Olech-Fudali E, Chibowski D, Skomra D, Walczyna B.
    Ann Univ Mariae Curie Sklodowska Med; 2001 Jun 15; 56():319-25. PubMed ID: 11977333
    [Abstract] [Full Text] [Related]

  • 20. [Microsatellite instability in endometrial neoplasms correlation with clinicopathologic parameters and estrogen receptor or progesterone receptor status].
    Song Y, Lang J.
    Zhonghua Fu Chan Ke Za Zhi; 2000 May 15; 35(5):273-6. PubMed ID: 11775905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.